Deal volume in the home health and hospice sector dipped slightly in the third quarter of 2019, down 23% with 20 publicly announced transactions, compared with 26 acquisitions in the second quarter, according to data from HealthCareMandA.com. Compared with the third quarter of 2018, home health and hospice M&A activity decreased by 20%, when 25 […]
Looking back, the third quarter got off to a great start. The Dow topped 27,000 and the S&P 500 passed 3,000 within the first two weeks. The NASDAQ followed, rising past 8,000 in about three weeks from the start. All were boosted by the Fed’s lowering its interest rate by a quarter point at its […]
Healthcare deal value in the second quarter totaled $138.7 billion, a slight 7% decrease from the first quarter’s $149.0 billion. Both quarters in 2019 featured a single, mega-billion-dollar deal—the $74 billion Bristol-Myers Squibb/Celgene deal in Q1 and the $87 billion AbbVie/Allergan hook-up in Q2—while the second quarter of 2018 included Takeda’s $81.5 billion deal for […]
With 431 deals announced in the second quarter, acquisition activity was 9% higher than the 394 transactions announced in the previous quarter. Year over year, however, deal volume was 11% lower than the same quarter in 2018, which had 484 deals. The first quarter of 2019 was the slowest of the previous four quarters, at […]
Second quarter deal volume was robust, based on preliminary results. Some 424 deals are on the books for the quarter, representing an 8% increase over the first quarter (394 deals). It’s still a hard comparison with Q2:18 numbers, which had 484 announcements, 12% higher than this year’s period. Spending remained high in the second quarter, […]
With 374 deals announced in the first quarter, acquisition activity was 25% lower than the 498 transactions announced in the previous quarter. Deal volume was also lower than the same quarter in 2018, down 16% compared with the 447 deals reported then. Deal volume in all four quarters of 2018 consistently closed above 440 deals, […]
Spending in the first quarter roared to nearly $150 billion, up 240% compared with the fourth quarter ($43.9 billion) and up 32% compared with the first quarter in 2018 ($113.4 billion). This quarter’s total would be halved if it weren’t for a single deal with a $74 billion price tag, Bristol-Myers Squibb’s (NYSE: BMY) acquisition […]
Talk of slowing global economic growth has swirled since late last year, following tariffs, trade wars, Brexit and you-name-it. The healthcare M&A market appeared to reflect the fears, as deal volume in the first quarter of 2019 slid 27% compared with the fourth quarter of 2018, and was down 19% compared with the same quarter […]
Spending in the first quarter, totaling $149 billion, beat both the previous quarter (up 239%) and the year-ago time period (up 31%). Three deals had a combined total of $113 billion, accounting for 76% of that spending. Without those three, the first quarter would have ended with approximately $36 billion, which would be 18% lower […]
Deal volume has climbed higher every year since 2012. Spending on those deals hasn’t been as predictable, which is why we watch deal volume more closely. But dollar signs attract attention, so here is where the preliminary results point. Combined spending in 2018 now stands at $330.3 billion and may rise slightly higher as we […]
